Article Text

other Versions

PDF
Prion infectivity in vCJD rectum

Statistics from Altmetric.com

This is a PDF-only article. The first page of the PDF of this article appears below.

PDF extract preview
  • Competing interests: JC is a Director and JC and JDFW are shareholders and consultants of D-Gen Limited, an academic spin-out company working in the field of prion disease diagnosis, decontamination and therapeutics. D-Gen markets one of the routine antibodies (ICSM 35) used in this study.

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Linked Articles